C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2004
11/25/2004	WO2004101752A2 Compounds for treatment of inflammation, diabetes and related disorders
11/25/2004	WO2004101581A2 Nitrogen-containing monodentate phosphines and their use in catalysis
11/25/2004	WO2004101540A2 Method for the production of phenylacetic acid derivatives
11/25/2004	WO2004101507A2 N-sulphonylated amino acid derivatives and use thereof as matriptase inhibitors
11/25/2004	WO2004101505A1 Novel compounds for treatment of obesity
11/25/2004	WO2004085385A3 Cannabinoid receptor ligands
11/25/2004	WO2004060862A3 Compounds having prolyl oligopeptidase inhibitory activity
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004	US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235858 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
11/25/2004	US20040235855 For therapy and prophylaxis of disease or condition in a subject which disease or condition is affected by phospholipase modulation such as restenosis
11/25/2004	US20040235854 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235827 For therapy and prophylaxis of disease or condition in a subject which disease or condition is affected by phospholipase modulation such as restenosis
11/25/2004	US20040235750 Thiocarbamate inhibitors of alpha-4 integrins
11/25/2004	DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin
11/25/2004	CA2525890A1 Nitrogen-containing monodentate phosphines and their use in catalysis
11/25/2004	CA2525886A1 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors
11/25/2004	CA2524780A1 Compounds for treatment of inflammation, diabetes and related disorders
11/24/2004	EP1479666A1 Ester compound and medicinal use thereof
11/24/2004	EP1478632A1 Substituted aryl alkenoic acid heterocyclic amides possessing pungent taste
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1478361A2 Arylsulfone derivatives
11/24/2004	EP1345952B1 Isolation of nucleic acids
11/24/2004	EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004	EP0929538B1 O?2 -arylated or o?2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates and o?2 -substituted 1- (2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
11/24/2004	CN1176941C Caspase inhibitors and the use thereof
11/24/2004	CN1176918C Intermediate of alpha-substituted benzene acetic acid derivate with farm pesticide activity
11/23/2004	US6822057 Olefin polymerization catalysts derived from Group-15 cationic compounds and processes using them
11/23/2004	US6821998 Arylamines as inhibitors of chemokine binding to US28
11/23/2004	US6821973 Compounds
11/23/2004	US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	US6821963 4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
11/23/2004	US6821396 Process for fractionating water-containing crude amine mixtures from amine synthesis
11/23/2004	CA2330942C Piperazine derivatives and process for the preparation thereof
11/23/2004	CA2290848C Cationic amino-di-anthraquinones, use, dyeing compositions containing them and dyeing processes
11/23/2004	CA2201845C Reactive amine catalysts and their use in polyurethane polymers
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099173A1 Multivalent inhibitors of serum amyloid p component
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004	WO2004099127A1 Novel compounds as kinase inhibitors
11/18/2004	WO2004099126A1 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
11/18/2004	WO2004099124A2 Novel bioisosteres of actinonin
11/18/2004	WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004	WO2004087700A8 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229883 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; therapy of metabolic, feeding, and sexual disorders including obesity
11/18/2004	US20040229869 For prophylaxis and therapy of medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229858 VLA-4 inhibitor compounds
11/18/2004	US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004	CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	CA2525302A1 Multivalent inhibitors of serum amyloid p component
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/17/2004	EP1477485A1 Aminophenol derivatives
11/17/2004	EP1476421A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
11/17/2004	EP1412335A4 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
11/17/2004	EP1296983B1 Novel process for the preparation of pyrazolopyrimidinones
11/17/2004	EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1066264B1 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	CN1547575A Novel phenylalkyl diamine and amide analogs
11/17/2004	CN1547570A Substituted c-cyclohexylmethylamine derivatives
11/17/2004	CN1547568A Preparation of 4-amino-1-naphthol ethers
11/17/2004	CN1546478A Improved method for preparing N-alkyl morpholine
11/17/2004	CN1176081C Intermediate for preparing sildenafil and preparing method thereof
11/17/2004	CN1176066C 1,1-and 1,2-disubsitituted cyclopropane compounds, preparation method thereof and drug compositions containing the same
11/16/2004	US6818765 Benzene-sulphonamide derivatives and their uses
11/16/2004	US6818644 Fluorene-9-carboxylic amides; inhibitors of microsomal triglyseride-transfer protein (mtp); antilipemic agents; atherosclerosis, diabetes, eating disorders, and pancreatitis
11/16/2004	US6818635 For therapy of bacterial infections and neoplasms,
11/16/2004	US6818327 Organic electroluminescence device
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096771A1 Biaryl compounds having activity at the 5ht5a receptor
11/11/2004	WO2004065360A3 Piperazine derivatives and their use as synthesis intermediates
11/11/2004	WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004	WO2003079983A3 Methods of preparing substituted tetracyclines with transition metal-based chemistries
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040224993 Diphenylurea compounds
11/11/2004	US20040224978 CCR8 inhibitors
11/11/2004	US20040224959 such as N-benzyl-3-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-N-methylbenzamide; for inhibition of secretion of apolipoprotein B lipoprotein from the liver; for treatment of hyperlipidemia, pancreatitis
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224928 For therapy of bacterial infections and neoplasms,
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	US20040224366 Valency platform molecules comprising aminooxy groups
11/11/2004	CA2536964A1 C-fms kinase inhibitors
11/10/2004	EP1474408A1 N-phenyl-2-pyrimidine-amine derivatives
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004	EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents
11/10/2004	EP1198453B9 N-(indolcarbonyl-)piperazin derivatives

1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 341